We present a pediatric patient treated with high dose intravenous immunoglobulin (IVIG) for acute immune thrombocytopenic purpura (ITP), who developed cerebral sinus thrombosis in the absence of any identifiable hypercoagulable state. This report describes the successful management of this rare complication in this challenging setting. This report shows IVIG induced cerebral sinus thrombosis in ITP.
- Anticoagulation therapy
- Cerebral sinus thrombosis
- Immune thrombocytopenic purpura
- Intravenous immunoglobulin
ASJC Scopus subject areas
- Pediatrics, Perinatology, and Child Health